1. A phase II Bayesian sequential clinical trial in advanced Waldenström macroglobulinemia patients treated with bortezomib: interest of addition of dexamethasone. Issue 11 (2nd November 2017) Authors: Leblond, Véronique; Morel, Pierre; Dilhuidy, Marie-Sarah; Leleu, Xavier; Soussain, Carole; Leprête, Stéphane; Dreyfus, Brigitte; Dartigeas, Caroline; Mahé, Béatrice; Anglaret, Bruno; Pégourié, Brigitte; Besson, Caroline; Aurran, Thérèse; Vekhoff, Anne; Tournilhac, Olivier; Banos, Anne; Oya, Hervé... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 11(2017) Page Start: 2615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗